Literature DB >> 17044807

Risk of atrial fibrillation with high-dose corticosteroids.

Bruno Chiappini1, Gebrine El Khoury.   

Abstract

Atrial fibrillation (AF) is the most common sustained arrhythmia observed in clinical practice. Some drugs have been associated with the onset of AF, but knowledge about the role of drugs in the development of AF is scarce. High-dose corticosteroid therapy has been associated with the development of AF, but this is mainly based on case reports. Therefore, the authors review the available data in the international literature about the cause-effect relationship between corticosteroid therapy and the onset of AF.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17044807     DOI: 10.1517/14740338.5.6.811

Source DB:  PubMed          Journal:  Expert Opin Drug Saf        ISSN: 1474-0338            Impact factor:   4.250


  3 in total

Review 1.  Primary Prevention of Atrial Fibrillation where are we in 2012?

Authors:  Massimo Imazio
Journal:  J Atr Fibrillation       Date:  2012-08-20

2.  Microphysiological heart-liver body-on-a-chip system with a skin mimic for evaluating topical drug delivery.

Authors:  Camilly P Pires de Mello; Carlos Carmona-Moran; Christopher W McAleer; Julian Perez; Elizabeth A Coln; Christopher J Long; Carlota Oleaga; Anne Riu; Reine Note; Silvia Teissier; Jessica Langer; James J Hickman
Journal:  Lab Chip       Date:  2020-01-23       Impact factor: 6.799

3.  Comparison of two different doses of single bolus steroid injection to prevent atrial fibrillation recurrence after radiofrequency catheter ablation.

Authors:  Da-Rae Kim; Hoyoun Won; Jae-Sun Uhm; Jong-Youn Kim; Jung-Hoon Sung; Hui-Nam Pak; Moon-Hyoung Lee; Boyoung Joung
Journal:  Yonsei Med J       Date:  2015-03       Impact factor: 2.759

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.